Because of Donald Trump’s long history of antivaccine statements, his meeting with Andrew Wakefield during the presidential campaign, and his meeting with Robert F. Kennedy, Jr. during the transition, antivaxers thought Trump would give them what they want. They were wrong, just the latest to realize that they’ve been conned. Is it so wrong for me to feel serious schadenfreude here?
No new Insolence today, I’m afraid. But I have an explanation.
This week, the FDA sent warning letters to 14 companies making unsupported claims that their products can treat cancer. Given the new administration’s determination to deregulate almost everything, but especially the FDA, is this the last time in the foreseeable future that such a crackdown will occur?
In less than two weeks, the Trump administration will have passed that magical “first 100 days” marker. Let’s check in and see how Donald Trump is shaping federal biomedical policy thus far. Hint: It’s deregulation über alles.
A few dozen antivaccine activists descended upon Washington, DC to protest and lobby their legislators. The protest itself was not impressive, but pro-science advocates shouldn’t let this pathetic march lead them to be complacent. Antivaxers are meeting with legislators, and President Trump is sympathetic to their aims.
